Sign in
The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development
Journal article   Open access  Peer reviewed

The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development

Sana O Alturki, Sawsan O Alturki, Jennifer Connors, Gina Cusimano, Michele A Kutzler, Abdullah M Izmirly and Elias K Haddad
Frontiers in immunology, Vol.11, pp.1880-1880
19/08/2020
PMID: 32973779

Abstract

Angiotensin-Converting Enzyme 2 Animals Antibodies, Neutralizing - immunology Antibodies, Viral - immunology Antibody-Dependent Enhancement Betacoronavirus - chemistry Betacoronavirus - immunology Clinical Trials as Topic Coronavirus Infections - immunology Coronavirus Infections - physiopathology Coronavirus Infections - prevention & control Coronavirus Infections - transmission Coronavirus Infections - virology COVID-19 COVID-19 Vaccines Drug Evaluation - methods Humans Pandemics - prevention & control Peptidyl-Dipeptidase A - metabolism Pneumonia, Viral - physiopathology Pneumonia, Viral - prevention & control Pneumonia, Viral - transmission Pneumonia, Viral - virology SARS-CoV-2 Spike Glycoprotein, Coronavirus - immunology Spike Glycoprotein, Coronavirus - metabolism Viral Vaccines - adverse effects Viral Vaccines - immunology
url
https://doi.org/10.3389/fimmu.2020.01880View
Published (Version of record) Open

Details